Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Family Practice · TOPEKA, KS · NPI 1912966979
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 536 | 129 |
| Simvastatin | Simvastatin | 379 | 96 |
| Pantoprazole Sodium | Pantoprazole Sodium | 295 | 84 |
| Amlodipine Besylate | Amlodipine Besylate | 270 | 75 |
| Lisinopril | Lisinopril | 267 | 84 |
| Atorvastatin Calcium | Atorvastatin Calcium | 265 | 82 |
| Tamsulosin Hcl | Tamsulosin Hcl | 222 | 57 |
| Omeprazole | Omeprazole | 215 | 60 |
| Losartan Potassium | Losartan Potassium | 201 | 52 |
| Gabapentin | Gabapentin | 191 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 189 | 48 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 186 | 32 |
| Metformin Hcl Er | Metformin Hcl | 157 | 35 |
| Montelukast Sodium | Montelukast Sodium | 156 | 41 |
| Tramadol Hcl | Tramadol Hcl | 144 | 41 |
| Metoprolol Succinate | Metoprolol Succinate | 140 | 43 |
| Allopurinol | Allopurinol | 124 | 29 |
| Pioglitazone Hcl | Pioglitazone Hcl | 122 | 29 |
| Zolpidem Tartrate | Zolpidem Tartrate | 118 | 26 |
| Oxycodone Hcl | Oxycodone Hcl | 107 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 106 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 85 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 85 | 28 |
| Fluticasone Propionate | Fluticasone Propionate | 83 | 25 |
| Pregabalin | Pregabalin | 82 | 22 |
| Alprazolam | Alprazolam | 81 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 80 | 19 |
| Bupropion Xl | Bupropion Hcl | 79 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 75 | 30 |
| Baclofen | Baclofen | 73 | 17 |
| Sertraline Hcl | Sertraline Hcl | 67 | 19 |
| Furosemide | Furosemide | 64 | 21 |
| Potassium Chloride | Potassium Chloride | 64 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 63 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 62 | 18 |
| Eliquis | Apixaban | 61 | 14 |
| Donepezil Hcl | Donepezil Hcl | 60 | 16 |
| Glipizide | Glipizide | 60 | 18 |
| Pravastatin Sodium | Pravastatin Sodium | 60 | 17 |
| Clonazepam | Clonazepam | 59 | suppressed |
| Prednisone | Prednisone | 58 | 53 |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 55 | 18 |
| Synthroid | Levothyroxine Sodium | 54 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 52 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 50 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 11 |
| Meloxicam | Meloxicam | 47 | 18 |
| Ozempic | Semaglutide | 44 | suppressed |
| Finasteride | Finasteride | 42 | 11 |
| Olanzapine | Olanzapine | 42 | suppressed |
| Atenolol | Atenolol | 41 | suppressed |
| Carvedilol | Carvedilol | 41 | 11 |
| Diclofenac Sodium | Diclofenac Sodium | 40 | 15 |
| Metformin Hcl | Metformin Hcl | 40 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | 14 |
| Fentanyl | Fentanyl | 39 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 37 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 37 | suppressed |
| Azithromycin | Azithromycin | 36 | 35 |
| Ondansetron Odt | Ondansetron | 35 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 34 | suppressed |
| Estradiol | Estradiol | 33 | suppressed |
| Irbesartan | Irbesartan | 32 | suppressed |
| Carisoprodol | Carisoprodol | 31 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 31 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 30 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 29 | suppressed |
| Famotidine | Famotidine | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 26 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 26 | suppressed |
| Klor-Con M20 | Potassium Chloride | 26 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 24 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 23 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Memantine Hcl | Memantine Hcl | 23 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 22 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 20 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 16 |
| Warfarin Sodium | Warfarin Sodium | 20 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 19 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 19 | suppressed |
| Valsartan | Valsartan | 19 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Levocarnitine | Levocarnitine (With Sugar) | 18 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 18 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 18 | suppressed |
| Spironolactone | Spironolactone | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 17 | suppressed |
| Myrbetriq | Mirabegron | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Premarin | Estrogens, Conjugated | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 11 |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Oxycontin | Oxycodone Hcl | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 11 |
| Ketoconazole | Ketoconazole | 15 | suppressed |
| Levetiracetam | Levetiracetam | 15 | suppressed |
| Lorazepam | Lorazepam | 15 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 14 | 13 |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 13 | suppressed |
| Flavoxate Hcl | Flavoxate Hcl | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Famciclovir | Famciclovir | 12 | suppressed |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Diazepam | Diazepam | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 11 | suppressed |
| Silodosin | Silodosin | 11 | suppressed |
| Sucralfate | Sucralfate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error